First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
Injectables for type 2 diabetes and weight loss could soon be a thing of the past. Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial evaluated the efficacy of Orforglipron compared to placebo in…

